Company intelligence / Profile preview

LuminX Biotech

Ownership: Private
Development stage: Commercial

Overview

Provides patented non-toxic fluorescent labeling kits to track viability/distribution of cellular products in vivo. Used to accelerate R&D and improve safety/efficacy assessment before clinical trials.

Therapeutic areas: OncologyImmunologyOther
Modalities: Cell therapyExosome-based therapyRegenerative medicine agent tracking technologyImmune cell tracking technology
Industry: Non-Drug Biotech

Partnerships

NBICiCANxIPASBE x TMUTacc+NBRPNHRI-TTIC programs

Beyond the preview

Go deeper on LuminX Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LuminX Biotech.

Explore the full profile